Logo image of CTEV

CLARITEV CORP (CTEV) Stock Overview

USA - NYSE:CTEV - US62548M2098 - Common Stock

70.66 USD
-0.7 (-0.98%)
Last: 10/28/2025, 10:13:58 AM

CTEV Key Statistics, Chart & Performance

Key Statistics
Market Cap1.16B
Revenue(TTM)935.54M
Net Income(TTM)-663374000
Shares16.47M
Float7.60M
52 Week HighN/A
52 Week LowN/A
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-40.5
PEN/A
Fwd PEN/A
Earnings (Next)11-07 2025-11-07
IPO2020-02-10
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Technology
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Technology


CTEV short term performance overview.The bars show the price performance of CTEV in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 50 100 150 200

CTEV long term performance overview.The bars show the price performance of CTEV in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of CTEV is 70.66 USD. In the past month the price increased by 35.64%.

CLARITEV CORP / CTEV Daily stock chart

CTEV Latest News, Press Relases and Analysis

CTEV Competitors/Peers

The largest stocks on the US markets in the "Health Care Technology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
VEEV VEEVA SYSTEMS INC-CLASS A 39.66 48.42B
DOCS DOXIMITY INC-CLASS A 45.4 12.67B
WAY WAYSTAR HOLDING CORP 35.37 7.49B
HTFL HEARTFLOW INC N/A 3.24B
CERT CERTARA INC 25.2 1.98B
SDGR SCHRODINGER INC N/A 1.62B
TDOC TELADOC HEALTH INC N/A 1.53B
PHR PHREESIA INC N/A 1.39B
GDRX GOODRX HOLDINGS INC-CLASS A 10.64 1.29B
LFMDP LIFEMD INC - LFMD 8 7/8 PERP N/A 1.07B
CCLDO CARECLOUD INC - CCLD 8 3/4 PERP N/A 901.42M
EVH EVOLENT HEALTH INC - A N/A 877.80M

About CTEV

Company Profile

CTEV logo image Claritev Corp. engages in providing data analytics and technology-enabled solutions. The company is headquartered in Mclean, Virginia and currently employs 2,700 full-time employees. The company went IPO on 2020-02-10. The Company’s services include analytics-based services, data & decision science services, network-based services, payment and revenue integrity, end-to-end surprise billing service, and Claritev payments. The firm uses its analytics-based services to price surprise bills and leverages reimbursement data from millions of claims repriced through these services and accepted by providers to assist in negotiations and calculate offers for arbitration when necessary. The company uses its payment integrity services on its network claims. The Company’s payment integrity offers advanced code editing, clinical negotiation, itemized bill review, coordination of benefits, subrogation, data mining, Medicare secondary payer validation, and end stage renal disease validation. The company provides solutions for the commercial market, government healthcare plans, and property and casualty healthcare payors.

Company Info

CLARITEV CORP

7900 Tysons One Place, Suite 400

McLean VIRGINIA US

Employees: 2700

CTEV Company Website

CTEV Investor Relations

Phone: 12127802000

CLARITEV CORP / CTEV FAQ

Can you describe the business of CLARITEV CORP?

Claritev Corp. engages in providing data analytics and technology-enabled solutions. The company is headquartered in Mclean, Virginia and currently employs 2,700 full-time employees. The company went IPO on 2020-02-10. The Company’s services include analytics-based services, data & decision science services, network-based services, payment and revenue integrity, end-to-end surprise billing service, and Claritev payments. The firm uses its analytics-based services to price surprise bills and leverages reimbursement data from millions of claims repriced through these services and accepted by providers to assist in negotiations and calculate offers for arbitration when necessary. The company uses its payment integrity services on its network claims. The Company’s payment integrity offers advanced code editing, clinical negotiation, itemized bill review, coordination of benefits, subrogation, data mining, Medicare secondary payer validation, and end stage renal disease validation. The company provides solutions for the commercial market, government healthcare plans, and property and casualty healthcare payors.


Can you provide the latest stock price for CLARITEV CORP?

The current stock price of CTEV is 70.66 USD. The price decreased by -0.98% in the last trading session.


Does CTEV stock pay dividends?

CTEV does not pay a dividend.


How is the ChartMill rating for CLARITEV CORP?

CTEV has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


Which stock exchange lists CTEV stock?

CTEV stock is listed on the New York Stock Exchange, Inc. exchange.


Is CLARITEV CORP (CTEV) stock a good buy?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on CTEV.


What is the expected growth for CTEV stock?

The Revenue of CLARITEV CORP (CTEV) is expected to grow by 1.46% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.


CTEV Technical Analysis

ChartMill assigns a technical rating of 6 / 10 to CTEV.


Chartmill TA Rating
Chartmill Setup Rating

CTEV Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to CTEV. Both the profitability and financial health of CTEV have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

CTEV Financial Highlights

Over the last trailing twelve months CTEV reported a non-GAAP Earnings per Share(EPS) of -40.5. The EPS decreased by -0.25% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -13.08%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%89.3%
Sales Q2Q%3.47%
EPS 1Y (TTM)-0.25%
Revenue 1Y (TTM)-2.03%

CTEV Forecast & Estimates

9 analysts have analysed CTEV and the average price target is 71.74 USD. This implies a price increase of 1.53% is expected in the next year compared to the current price of 70.66.

For the next year, analysts expect an EPS growth of 76.94% and a revenue growth 1.46% for CTEV


Analysts
Analysts80
Price Target71.74 (1.53%)
EPS Next Y76.94%
Revenue Next Year1.46%

CTEV Ownership

Ownership
Inst Owners40.19%
Ins Owners6.91%
Short Float %8.04%
Short Ratio5.11